Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of basal plus one insulin regimen versus biphasic insulin regimen in type 2 diabetes
2008-007026-19Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Basal plus one regimen (Lantus + Apidra) with Biphasic insulin regimen (NovoMix 30) (2 arms). Primary endpoints: Primary HbA1c non-inferiority at 6 months and Proportion achieving HbA1c < 7%. Started Apr 2009; status: completed.
02
Drugs
insulin glarginehuman insulinbiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-007026-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007026-19.